Stephanie Gaillard
Director of Gynecologic Cancer Trials · Johns Hopkins University School of Medicine
Credentials: · · · · ·
History
- 2009–2011
Medical Oncology
- 2006–2009
Internal Medicine
2002–2006
Research
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
Molecular Cell · 2005 · 964 citations
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024
Journal of the National Comprehensive Cancer Network · 2023 · 349 citations
The Lancet · 2022 · 196 citations
22 papers
10 papers
8 papers
8 papers
8 papers
8 papers
7 papers
6 papers
Grants
- 2018–2029
National Cancer Institute · P50
Project lead · $1.2M · Johns Hopkins University
- 2023–2028
National Cancer Institute · R50
Contact PI · $438.7K · Johns Hopkins University
Clinical trials
- 2025–2029
Principal investigator · Recruiting · Phase 3
AstraZeneca
- 2025–2030
A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
Principal investigator · Recruiting · Phase 1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2025–2029
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
Principal investigator · Recruiting · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2019–2025
Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
Principal investigator · Completed · Phase 1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins